Did you know?

The IWMF raised more than five million dollars for WM medical research

Did you know?

The IWMF raised more than 60 support groups in North America and nearly 20 others world-wide

Did you know?

The IWMF has a current worldwide membership of nearly 4,000

Did you know?

IWMF-TALK is a wonderful place to share information and learn from other survivors

Did you know?

Each year 1,500 new cases of Waldenstrom's macroglobulinemia are diagnosed in the USA

Did you know?

Volunteers at the IWMF Telephone Lifeline are waiting to share their experiences with you

Did you know?

You can order DVD recordings of past WM Educational Forums online or by mail

Did you know?

All IWMF programs and services are funded by WM survivors, caregivers, friends, and family

FDA Grants Breakthough Therapy Designation for Drug for WM - read more!

February 01 - May 31, 2013


FDA Grants Breakthough Therapy Designation for Drug for WM - read more!



On February 12, 2013, it was announced that the FDA granted breakthrough therapy designation for ibrutinib specifically for use with WM and mantle cell lymphoma.  This is the FIRST time any drug has been specifically given approval for the treatment of WM, and holds much promise as it continues into Phase III trials.  Read more in the IWMF press release about it!

 

French version of press release: Communique de presse - Bulletin Special.



« Back to events